Clinical trials for COVID-19 should include sex as a variable

Abstract
This Viewpoint calls on investigators that are developing and testing therapeutic and prophylactic approaches for COVID-19 to design studies that are inclusive of male-female differences.

This publication has 24 references indexed in Scilit: